Stryker Recalls Boston Scientific's Guider Guide Catheter

This article was originally published here

Stryker, Boston ScientificStryker‘s (NYSE:SYK) neurovascular division this month released a recall notice for Boston Scientific‘s (NYSE:BSX) Guider guide catheter it distributes over issues with an incomplete seal that could lead to blood loss.

Both companies are coordinating to enable the recall and return of affected products, according to the recall release.

No deaths or adverse events were reported with the recall, according to the notice, with the most severe potential effect being identified as insignificant blood loss after device introduction. No patients previously treated with the device are at risk, according to the release.

The company said that the defect would be evident during normal device preparation through standard device inspection steps or after flushing the guider catheter with saline.

Stryker said the issue was caused by a manufacturing non-conformance issue which can lead to potential hub leaks in the finished products.

The recall affects 50 different catalog and lot numbers, according to the recall release. Stryker requested that customers with the products return the devices to Stryker.

In July, Stryker’s Sustainability Solutions biz recalled a select number of re-sterilized AngioDynamics (NSDQ:ANGO) Soft Vu omni flush angiographic catheters due to reports of tip separation.

AngioDynamics said it is not associated with the recall, and that the devices affected have their own FDA clearance and are “specifically Stryker Sustainability Solutions Products.”

The devices were “part of Stryker’s (formerly Ascent Healthcare Solutions) open-but-unused program, which was strictly a sterilization service for open-but-unused devices,” according to an email statement from Stryker.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply